Free Trial

Stevanato Group (NYSE:STVN) Shares Down 8.6% - Time to Sell?

Stevanato Group logo with Medical background

Key Points

  • Stevanato Group's stock price fell by 8.6%, trading as low as €23.24 ($27.02) during mid-day trading, significantly down from its previous closing price of €25.58 ($29.74).
  • A consensus rating of "Moderate Buy" has been established by analysts, with seven analysts providing varying ratings, including one strong buy.
  • Institutional investors have shown increased interest in Stevanato Group, with significant stake increases, such as Bessemer Group raising its stake by 14,623.3%.
  • Need Better Tools to Track Stevanato Group? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) fell 8.6% on Tuesday . The stock traded as low as €23.24 ($27.02) and last traded at €23.37 ($27.17). 218,131 shares changed hands during trading, a decline of 36% from the average session volume of 338,522 shares. The stock had previously closed at €25.58 ($29.74).

Analyst Ratings Changes

Several brokerages recently weighed in on STVN. Stephens upgraded Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. William Blair reiterated an "outperform" rating on shares of Stevanato Group in a research report on Monday, June 30th. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Stevanato Group has an average rating of "Moderate Buy" and a consensus target price of €25.13 ($29.22).

Read Our Latest Stock Report on Stevanato Group

Stevanato Group Stock Performance

The company has a debt-to-equity ratio of 0.25, a current ratio of 1.79 and a quick ratio of 1.26. The firm has a fifty day simple moving average of €24.52 and a 200 day simple moving average of €22.44. The company has a market capitalization of $7.12 billion, a price-to-earnings ratio of 43.52, a price-to-earnings-growth ratio of 2.38 and a beta of 0.55.

Institutional Trading of Stevanato Group

Institutional investors have recently bought and sold shares of the business. Whittier Trust Co. acquired a new stake in Stevanato Group in the first quarter valued at approximately $27,000. Twin Tree Management LP acquired a new stake in Stevanato Group in the first quarter valued at approximately $29,000. Johnson Financial Group Inc. acquired a new stake in Stevanato Group in the fourth quarter valued at approximately $41,000. SVB Wealth LLC acquired a new stake in Stevanato Group in the first quarter valued at approximately $46,000. Finally, Van Berkom & Associates Inc. grew its holdings in Stevanato Group by 33.3% in the first quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company's stock valued at $49,000 after purchasing an additional 600 shares during the period.

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Read More

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines